New treatment for Alzheimer's disease has positive results in clinical trials
Patients who purchase cheap medication from Canada may find a wealth of different products at substantially lower costs.
Patients who purchase cheap medication from Canada may find a wealth of different products at substantially lower costs. Canadian internet pharmacies provide a range of drugs to treat many conditions, from heart ailments to illnesses of the central nervous system, and a new remedy from Adeona Pharmaceuticals may soon be available to patients who suffer from cognitive impairment.
The treatment, known as reaZin, is designed to increase levels of zinc in the serum of individuals who have Alzheimer's disease, as well as maintain positive mental status among these people. Adeona recently announced positive findings in an intensive clinical study that evaluated the efficacy and safety of this drug.
"We are highly encouraged by the results from this clinical study, especially achieving the primary outcome with the statistically significant change in the free copper-to-zinc ratio in the treatment group over the placebo group," said lead researcher George J. Brewer.
He added that the composite score supports cognitive benefit in the treatment group compared to the placebo group, which may be of ultimate importance with respect to a future treatment for Alzheimer's disease.
The development of such medications - and their impending availability from sources like Canadian online pharmacies - may prove beneficial to individuals who have the neurodegenerative disorder.
|
